{
    "name": "botulinum antitoxin, heptavalent",
    "comment": "Rx",
    "other_names": [
        "HBAT"
    ],
    "classes": [
        "Antidotes",
        "Other"
    ],
    "source": "https://reference.medscape.com/drug/hbat-botulinum-antitoxin-heptavalent-999488",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C; experience limited in pregnant women; however, A, B and E antitoxins have been given to pregnant women without causing harm to the mother or the fetus",
            "Being pregnant is not a reason to avoid H-BAT administration for botulism; benefit to the mother and the fetus from receiving heptavalent botulinum antitoxin should be weighed against risk of harm from treatment; decisions should be made on a case-by-case basis by treating physician",
            "Lactation: Unknown whether distributed in breast milk"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Unknown whether distributed in breast milk"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "No absolute contraindications identified in individual with high-risk exposure to botulinum toxin"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Allergic reactions are expected to be infrequent",
                "Immediate systemic reactions (allergic reactions, shock, anaphylaxis) can occur whenever an equine product is administered; immediate reaction usually occurs within 30 minutes after initiating infusion",
                "Infuse IV slowly as described under administration in adult dosing section",
                "Milder allergic reactions (eg, mild bronchoconstriction, hypotension, hives) may be more common"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Investigational IND",
            "percent": null
        },
        {
            "name": "adverse drug reactions unknown",
            "percent": null
        },
        {
            "name": "see cautions",
            "percent": null
        }
    ]
}